Increased Levels of Antigen-Bound β-Amyloid Autoantibodies in Serum and Cerebrospinal Fluid of Alzheimer’s Disease Patients (original) (raw)
Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression
Cristiana Barbati
Autoimmunity Reviews, 2010
View PDFchevron_right
Brain-reactive autoantibodies prevalent in human sera increase intraneuronal amyloid-β(1-42) deposition
Nikhil Thaker
Journal of Alzheimer's disease : JAD, 2011
View PDFchevron_right
Beta-amyloid auto-antibodies are reduced in Alzheimer's disease
Dwight German
Journal of Neuroimmunology, 2014
View PDFchevron_right
Decreased serum amyloid β1–42 autoantibody levels in Alzheimer’s disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid β1–42 peptide
Yansheng Du
Biological Psychiatry, 2005
View PDFchevron_right
Elevation of β-Amyloid 1-42 Autoantibodies in the Blood of Amnestic Patients With Mild Cognitive Impairment
Paola Bossu
Archives of Neurology, 2010
View PDFchevron_right
Distinct Patterns of Antiamyloid-β Antibodies in Typical and Atypical Alzheimer Disease
Olivier Colliot
Archives of Neurology, 2012
View PDFchevron_right
Human Antibodies Reactive with B-Amyloid Protein in Alzheimer's Disease
Felicia Gaskin
2000
View PDFchevron_right
Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Fabrizio Piazza
Frontiers in Neurology
View PDFchevron_right
Antigenantibody dissociation in Alzheimer disease: a novel approach to diagnosis
R. Friedland, Xiongwei Zhu, Robert B Petersen, George Perry
Journal of Neurochemistry, 2008
View PDFchevron_right
Immune complexes of auto-antibodies against Aβ1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients
Andreas Henkel
Molecular Psychiatry, 2007
View PDFchevron_right
Early Detection of Alzheimer’s Disease-Related Pathology Using a Multi-Disease Diagnostic Platform Employing Autoantibodies as Blood-Based Biomarkers
George Godsey
Journal of Alzheimer's Disease
View PDFchevron_right
Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies
Luisa Chiapparini
Annals of Neurology, 2013
View PDFchevron_right
Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers
George Godsey
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2016
View PDFchevron_right
Generation of autoantibodies towards Alzheimer's disease vaccination
Beka Solomon
Neurobiology of Aging, 2000
View PDFchevron_right
Immune response to Aβ-peptides in peripheral blood from patients with Alzheimer's disease and control subjects
Bernard Croisile
Neuroscience Letters, 2004
View PDFchevron_right
Naturally Occurring Autoantibodies against -Amyloid: Investigating Their Role in Transgenic Animal and In Vitro Models of Alzheimer's Disease
Michael Bacher
Journal of Neuroscience, 2011
View PDFchevron_right
Specific reactivity of mild/severe Alzheimer’s disease patient’s sera to antibody against Aβ1-40 epitope 17-21
Funda Hatip
Acta Neurologica Scandinavica, 2007
View PDFchevron_right
Dissociated amyloid-β antibody levels as a serum biomarker for the progression of Alzheimer’s disease: A population-based study
Alan Lerner
Experimental Gerontology, 2010
View PDFchevron_right
Naturally occurring autoantibodies interfere with β-amyloid metabolism and improve cognition in a transgenic mouse model of Alzheimer's disease 24 h after single treatment
Michael Bacher
Translational psychiatry, 2013
View PDFchevron_right
Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly
F. Sardi
Autoimmunity Reviews, 2011
View PDFchevron_right
Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study
George Perry
Experimental gerontology, 2010
View PDFchevron_right
Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals
Paul Szabo, Marc Weksler
Experimental Gerontology, 2002
View PDFchevron_right
Naturally Occurring Autoantibodies against β-Amyloid: Investigating Their Role in Transgenic Animal andIn VitroModels of Alzheimer's Disease
Yansheng Du
The Journal of Neuroscience, 2011
View PDFchevron_right
The Pathology of Alzheimer Disease Elicits an In Vivo Immunological Response
Robert Friedland
American Journal of Immunology, 2007
View PDFchevron_right
Biomarkers of inflammation and amyloid-β phagocytosis in patients at risk of Alzheimer disease
Robert Veerhuis
Experimental Gerontology, 2010
View PDFchevron_right
Circulating immune complexes of Aβ and IgM in plasma of patients with Alzheimer's disease
Andrea Marcelo
Alzheimer's & Dementia, 2009
View PDFchevron_right
Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer’s disease
xing wei
Journal of Neurology Neurosurgery and Psychiatry, 2004
View PDFchevron_right
Immunological Aspects of Alzheimer??s Disease
piet eikelenboom
BioDrugs, 2001
View PDFchevron_right
A Specific Enzyme-Linked Immunosorbent Assay for Measuring β-Amyloid Protein Oligomers in Human Plasma and Brain Tissue of Patients With Alzheimer Disease
Ganesh Shankar
Archives of Neurology, 2009
View PDFchevron_right
Intravenous immunoglobulins containing antibodies against -amyloid for the treatment of Alzheimer's disease
Yansheng Du
Journal of Neurology, Neurosurgery & Psychiatry, 2004
View PDFchevron_right
Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue
Jurgen Claassen
Analytical Biochemistry, 2013
View PDFchevron_right